Who owns 10x Genomics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of TXG from SEC Form 13F filings across 392 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 392 institutions disclosed 128.4M shares of 10x Genomics, Inc. worth $4.92B — about 98.8% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
392
13F holders
$4.92B
value, 2026 filers
98.8%
of shares outstanding (128.4M sh)
105
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of TXG's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 17.6M | $675.9M | 0.0% | 13.6% | -0.6% |
| 2 | BlackRock, Inc. | 10.8M | $414.2M | 0.0% | 8.3% | +7.2% |
| 3 | ARK Investment Management LLC | 10.0M | $383.5M | 2.5% | 7.7% | -14.6% |
| 4 | VANGUARD PORTFOLIO MANAGEMENT LLC | 7.0M | $267.7M | 0.0% | 5.4% | +1.0% |
| 5 | Quantinno Capital Management LP | 5.5M | $209.7M | 0.3% | 4.2% | +1.1% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 5.1M | $194.9M | 0.0% | 3.9% | -3.5% |
| 7 | PRICE T ROWE ASSOCIATES INC /MD/ | 4.5M | $174.0M | 0.0% | 3.5% | +2681.0% |
| 8 | Sumitomo Mitsui Trust Group, Inc. | 4.2M | $160.8M | 0.1% | 3.2% | -17.9% |
| 9 | Amova Asset Management Americas, Inc. | 4.2M | $160.7M | 2.1% | 3.2% | -17.9% |
| 10 | MORGAN STANLEY | 3.4M | $128.5M | 0.0% | 2.6% | +26.2% |
| 11 | GOLDMAN SACHS GROUP INC | 3.1M | $120.7M | 0.0% | 2.4% | -20.7% |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 3.1M | $118.2M | 0.0% | 2.4% | +6.1% |
| 13 | STATE STREET CORP | 2.8M | $107.4M | 0.0% | 2.2% | +8.2% |
| 14 | CITADEL ADVISORS LLC | 2.8M | $106.6M | 0.0% | 2.1% | +273.7% |
| 15 | DIMENSIONAL FUND ADVISORS LP | 2.2M | $85.3M | 0.0% | 1.7% | +8.9% |
| 16 | AQR CAPITAL MANAGEMENT LLC | 2.0M | $74.7M | 0.0% | 1.6% | -20.2% |
| 17 | JACOBS LEVY EQUITY MANAGEMENT, INC | 2.0M | $77.4M | 0.3% | 1.6% | -11.5% |
| 18 | Point72 Asset Management, L.P.NEW | 1.9M | $71.0M | 0.1% | 1.4% | new |
| 19 | Capital World Investors | 1.5M | $57.2M | 0.0% | 1.1% | +2.8% |
| 20 | T. Rowe Price Investment Management, Inc. | 1.3M | $48.6M | 0.0% | 1% | -1.0% |
| 21 | NORTHERN TRUST CORP | 1.1M | $43.9M | 0.0% | 0.9% | +9.2% |
| 22 | Nuveen, LLC | 1.1M | $43.1M | 0.0% | 0.9% | +79.7% |
| 23 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.1M | $41.7M | 0.0% | 0.8% | -3.5% |
| 24 | Casdin Capital, LLC | 1.1M | $40.3M | 2.0% | 0.8% | -53.8% |
| 25 | Connor, Clark & Lunn Investment Management Ltd. | 988,320 | $37.9M | 0.1% | 0.8% | +5.3% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.